KRT18 and cancer: Among them, pORF-HGFK1 exhibited significantly more potent effects on Eps15, CK18, and CK8 compared to pEndo, suggesting that these three proteins may have contributed to the anti-cancer stem-cell activity of HGFK1 (Figure 7B).